Skip to main content

Table 2 Comparison in clinical, functional, laboratory parameters and radiological situation at 3 and 12 months after hospital discharge

From: Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value

Variables

At 3 months

At 12 months

P

Dyspnea according to mMRC

N = 194

N = 194

 

Dyspnea ≥ 1, N (%)

89 (45.9)

77 (39.7)

0.38

Dyspnea ≥ 2, N (%)

20 (10.3)

21 (10.8)

0.70

Dyspnea

0 (0–1)

0 (0–1)

0.84

Health status according to Nottingham Health Profile

N = 189

N = 189

 

Energy

0 (0–33)

0 (0–33)

0.53

Pain

0 (0–40.6)

0 (0–37.5)

0.72

Physical mobility

12.5 (0–37)

12.5 (0–37.5)

0.52

Emotional reactions

11.1 (0–33.3)

11.1 (0–33.3)

0.61

Sleep

20 (0–60)

20 (0–60)

0.72

Social isolation

0 (0–0)

0 (0–0)

0.89

Number of limited areas

3 (2–4)

3 (1–5)

0.64

Spirometry

N = 194

N = 194

 

FVC, % of predicted

103 (92–115)

107 (98–117)

0.0001

FVC < LLN, N (%)

10 (5.2)

3 (1.6)

0.03

FEV1, % of predicted

103 (92–115)

105 (93–115)

0.32

FEV1 < LLN, N (%)

15 (7.7)

7 (3.6)

0.02

Gas difusión

N = 189

N = 187

 

DLNO, % of predicted

79 (68.5–87.5)

83 (73–93)

0.0001

DLNO < LLN, N (%)

55 (29.1)

36 (19.3)

0.02

DLCO, % of predicted

86 (74–97)

94 (83–109)

0.0001

DLCO < LLN, N (%)

32 (16.9)

18 (9.6)

0.02

VA, % of predicted

87 (78.5–94)

97 (89–110)

0.0001

KNO, % of predicted

90 (83–99)

86 (80–93)

0.0001

KNO < LLN, N (%)

18 (9.5)

21 (11.2)

0.39

KCO, % of predicted

96 (84–105)

93 (83–102)

0.0001

KCO < LLN, N (%)

10 (5.3)

10 (5.3)

0.99

DMCO, % of predicted

69 (57–79.5)

71 (60–81)

0.001

DMCO/VA, % of predicted

83 (74–93.7)

78 (69–86)

0.0001

Vc, % of predicted

85 (74–98)

97 (84–110)

0.0001

Vc/VA, % of predicted

101 (88–112.5)

100 (89–113)

0.40

DLNO/DLCO

4.5 (4.3–4.6)

4.3 (4.2–4.5)

0.0001

DMCO/Vc

1.4 (1.2–1.7)

1.3 (1.1–1.5)

0.0001

Exercise capacity (6MWT)

N = 181

N = 179

 

6-min walking distance, m

456 (391–521)

510 (465–558)

0.0001

Initial oxygen saturation, %

98 (97–99)

98 (97–98)

0.08

Final oxygen saturation, %

97 (95–98)

97 (96–97)

0.23

Initial Borg scale dyspnea (1–10)

0 (0–0)

0 (0–0)

0.64

Final Borg scale dyspnea (1–10)

2 (0–4)

1 (0–5)

0.41

Laboratory parameters

N = 192

N = 192

 

D-dimer, ng/mL

339 (225–565-5)

328 (315–515)

0.09

Lactate deshydrogenase, U/L

195 (173–217)

191 (163–308)

0.06

Chest X-ray

N = 194

N = 194

 

Persistence of any lung injuries, N (%)

54 (27.8)

11 (5.7)

0.0001

Chest CT

N = 87

N = 70

 

Score extension affectation

6 (0–11)

5 (3–8)

0.0001

Ground glass opacities > 25%, N (%)

27 (31)

13 (18.6)

0.0001

Presence of reticulation, N (%)

24 (27.6)

21 (30)

0.38

Presence of bronchiectasis, N (%)

18 (20.7)

20 (28.6)

0.80

  1. Median (25th and 75th percentile). Wilcoxon test
  2. FVC forced vital capacity, LLN lower limits of normal, FEV1 forced expiratory volume in first one second, DLNO diffusion capacity of nitric oxide, DLCO diffusion capacity of carbon monoxide, VA alveolar lung volume, KNO rate of uptake of nitric oxide from alveolar gas, KCO rate of uptake of carbon monoxide from alveolar gas, DMNO membrane conductance of nitric oxide, VC pulmonary capillary blood volume, 6MWT six-minute walk test, CT computerized tomography